Hah, lucky you. Currently it would have to hit $1.48 to break even for me.
Not that I would sell at that point. I've decided I'm either doubling my money on this stock or losing it all. And I think if it ever gets back up around $1.50 it would have to be for a good reason, a reason that would probably drive it well beyond that.
We shall see!
Ugh. Unfortunately not true.
As of April 2nd Inventiv's claims still stand.
If there is evidence otherwise I would love to see it
It appears anything said by anyone, positive or negative, sets you off.
What part of what I said has you in arms? As I said, there isn't a compelling negative side to this. But there is a common misunderstanding that this agreement to not charge Cel-Sci for an additional $2 million in services is somehow an investment. It is not. It is Ergomed agreeing to do an additional $2million in services for Cel-Sci, for free.
Cel-Sci receives no cash from this deal. Ergomed receives no stock from this deal. They receive a one digit percentile (lets assume 9 percent) for agreeing to do them this solid. Which, lets face it, is sorely needed GREAT.
Everything you said is irrelevant except for the "everyday is on day closer to completion,"
I certainly hope you're right. I don't give a s**t what you think I believe. You're as fanatically and blindly bullish as any bashing idiot on this board ever thought about being.
You give them credibility because your nonsensical, all-caps, asterisk-filled posts look an inverted version of theirs.
It's not helping.
Try having a rational conversation. See what that does.
I'm all for it, it's great news. But keep in mind that the $2million is not an investment, it is merely $2 million in services Cel-Sci doesn't have to pay.
Which, I guess that is an investment. It's just not a purchase of stocks or money in the bank for CVM.
All around though, good news. No matter what the snakes say there isn't really a compelling negative side to this
Yea this definitely made my ears perk up, finally some good news.
Curious, how do you think this is going to effect inventiv? (not trying to argue, just curious)
They've got billions so they probably see 2 million as nothing
meh, not completely dead. close though.
I still check it to see if there's news I missed.
Something will happen eventually.
Just to be clear, it's a total of $67,000 they paid for this article, when accounting for the equity at its current price.
I don't refute the points of the article. I do wish the source were more credible and unsolicited.
A company running a televised advertising campaign (toyota, subway) to buy *their product* is very different than a company paying a PR service in the guise of a media outlet to advocate buying *company shares*.
Two very different things.
You constantly speak of professional stock manipulators. What is a firm that accepts money and equity in return for positive stock sentiment? Small Cap Network does that for a profession. That is how they make money. Literally a professional stock manipulator.
Would they have written that article without being paid?
Would anyone else?
How would it seem if Subway or Toyota paid a PR firm to publish "news" coverage about their company shares? Pretty fishy.
Cel-Sci and all of their funds should be focused on their trials, on their research, on their eventual product. The same "coverage" they just wasted $40,000 on could easily be achieved if they were as forthcoming and transparent about phase 3 progress, and by that I mean at least the stuff they're legally allowed to share.
I'm not even going to get into it, but they have a history of leaving fair questions from real investors unanswered.
I am two years into holding CVM. I would never sell at this point; It's already lost over half its value and there's still the outside chance it may recover.
Positive trial outcome, positive HPV trial news, positive Phase 3 news. All very good potential catalysts.
You tend to be so fanatical about cvm that you're impossible to have a conversation or debate with. The only reason you're not on ignore at this point is because you do occasionally post really useful, positive information. Plus, I suppose one voice of hope is a little nice in this snakepit.
I'm not against good coverage, we need it. But I don't like the idea of manufactured coverage. It has given me a false sense of hope for far too long. Read the fine print at the bottom:
"On The Market is receiving a fee of forty two thousand dollars and fifty thousand shares of restricted stock as compensation for the distribution of this commentary and other advertisements. Since we are receiving compensation in the advertised company there is an inherent conflict of interest in our statements and opinions and such statements and opinions cannot be considered independent."
That's fourty two thousand dollars Cel-Sci didn't need to spend. They pay for these articles, the stock goes up 2 or 3 cents, then a week later it's back down. If the team were more transparent about what is happening in the trials, coverage would come naturally.